| Financial Year |
March 31 2023 |
| Monetary Funds |
2,519,609,443.00 |
| Held-for-trading Financial Assets |
2,835,792,482.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
159,854,541.00 |
| Advances to Suppliers |
39,211,034.00 |
| Other Receivables |
102,960,494.00 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
676,071,153.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
369,346,493.00 |
| Other Current Assets |
70,551,289.00 |
| Total Current Assets |
6,773,396,929.00 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
20,494,242.00 |
| Investment Properties |
20,189,076.00 |
| Fixed Assetes |
1,276,895,830.00 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
9,047,110.00 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
6,905,101.00 |
| Deferred Income Tax Assets |
71,579,342.00 |
| Other Non-Current Assets |
2,631,381,362.00 |
| Sub-Total of Non-Current Assets |
4,223,169,606.00 |
| Total Assets |
10,996,566,535.00 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
719,353,500.00 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
54,607,699.00 |
| Taxes Payable |
86,174,414.00 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
119,871,567.00 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
16,475,678.00 |
| Other Current Liabilities |
40,257,835.00 |
| Sub-Total of Current Liabilities |
1,120,429,006.00 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
85,928,901.00 |
| Total Liabilities |
1,206,357,907.00 |
| Paid-In Capital(Or Share Stock) |
93,691,616.00 |
| Capital Surplus |
5,125,647,468.00 |
| Surplus Reserve |
46,845,808.00 |
| LESS:Treasury Stock |
61,072,574.00 |
| Undistributed Profits |
4,580,210,693.00 |
| Minority Stockholder's Interest |
991,345.00 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
9,789,217,283.00 |
| Owner's Equity（Stockholder's Equity） |
9,790,208,628.00 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
10,996,566,535.00 |
